Choose your location and language
Choose your country:
- Order tests, track orders, get results, and more.
N0 Report Explained - Patients Age >50 / RS 0-25
N0 Report Explained - Patients Age >50 / RS 26-100
May 2025
![[ESMO24] Insights from ESMO24.](/_next/image?url=%2F-%2Fjssmedia%2Fproject%2Fheadless%2Foncotype%2Fen%2Fimages%2Fnews-and-resources%2Fvideos%2Fthumbnail_video_esmo24_insights.png%3Fh%3D610%26iar%3D0%26w%3D1084%26rev%3D-1%26hash%3D737CFDF8C7788963E5494F5C9659B20D&w=3840&q=75)
![[ESMO24] Evolving role of MRD guided decision making in early breast cancer.](/_next/image?url=%2F-%2Fjssmedia%2Fproject%2Fheadless%2Foncotype%2Fen%2Fimages%2Fnews-and-resources%2Fvideos%2Fthumbnail_video_esmo24_evolvingroleofmrd.png%3Fh%3D607%26iar%3D0%26w%3D1087%26rev%3D-1%26hash%3D18990D72646E0A1F99D09B5ED9D89D1C&w=3840&q=75)
![[ESMO24] Tissue-based genomics to guide adjuvant therapy decisions.](/_next/image?url=%2F-%2Fjssmedia%2Fproject%2Fheadless%2Foncotype%2Fen%2Fimages%2Fnews-and-resources%2Fvideos%2Fthumbnail_video_esmo24_tissue.png%3Fh%3D610%26iar%3D0%26w%3D1093%26rev%3D-1%26hash%3D162ED16B16223AE79C2BBF357FC71917&w=3840&q=75)
Introduction to MRD in breast cancer
![[ESMO24] Introduction to MRD in breast cancer.](/_next/image?url=%2F-%2Fjssmedia%2Fproject%2Fheadless%2Foncotype%2Fen%2Fimages%2Fnews-and-resources%2Fvideos%2Fthumbnail_video_esmo24_introductiontomrd.png%3Fh%3D608%26iar%3D0%26w%3D1093%26rev%3D-1%26hash%3D019053DA612FDD25C837BED8A61F62E0&w=3840&q=75)
![[ESMO24] Evolving role of genomic assays in early breast cancer.](/_next/image?url=%2F-%2Fjssmedia%2Fproject%2Fheadless%2Foncotype%2Fen%2Fimages%2Fnews-and-resources%2Fvideos%2Fthumbnail_video_esmo24_evolving.png%3Fh%3D611%26iar%3D0%26w%3D1081%26rev%3D-1%26hash%3DA129A41148175ADA1B21028FFDAE98F0&w=3840&q=75)
Patient's awareness and understanding of genomic testing
Richard Simcock, UK
Christos Markopoulos, Greece
The Oncotype DX® Test: Evolution of UK Real World Outcomes Data
Miss Marianne Dillon, Consultant Oncoplastic Breast Surgeon from Swansea Bay University Health Board, Dr Wendy Taylor Consultant Clinical Oncologist...
Follow the evidence to help guide chemotherapy decisions for early breast cancer patients
Dr Richard Simcock, Consultant Clinical Oncologist, Brighton and Sussex University Hospitals NHS Trust, and Dr David Hyams, Medical Director
Clinical utility of multigene assays in early breast cancer: Predictive tests
A presentation by Professor Christos Markopoulos from the University of Athens in Greece talking about the predictive ability of multigene assay...
